Terms: = Thyroid cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
25 results:
1. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract] [Full Text] [Related]
2. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
Zhu F; Li F; Xie X; Wu Y; Wang W
Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
[TBL] [Abstract] [Full Text] [Related]
4. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract] [Full Text] [Related]
5. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of the Relationship Between the Quality of Small Biopsy Specimens of
Non-small Cell Lung cancer and the Mutation Rate of EGFR Gene].
Li Y; Gu Y; Jiang J
Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):331-337. PubMed ID: 34034456
[TBL] [Abstract] [Full Text] [Related]
7. Does Multifocal Papillary thyroid Microcarcinoma With a Total Tumor Diameter >1 cm Indicate Poor Biological Behavior? The Evidence is Insufficient.
Zhou B; Wei L; Qin J
Endocr Pract; 2021 Feb; 27(2):131-136. PubMed ID: 33547013
[TBL] [Abstract] [Full Text] [Related]
8. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
Hegde A; Andreev-Drakhlin AY; Roszik J; Huang L; Liu S; Hess K; Cabanillas M; Hu MI; Busaidy NL; Sherman SI; Dadu R; Grubbs EG; Ali SM; Lee J; Elamin YY; Simon GR; Blumenschein GR; Papadimitrakopoulou VA; Hong D; Meric-Bernstam F; Heymach J; Subbiah V
ESMO Open; 2020 Oct; 5(5):e000799. PubMed ID: 33097651
[TBL] [Abstract] [Full Text] [Related]
9. Should we consider thyroid gland as an organ at risk in carcinoma breast patients receiving adjuvant radiation by conformal technique? A single institute dosimetric study.
Madisetty A; Suryadevara A; Chinta SK; Vuppu S; R Marella VR
Indian J Cancer; 2020; 57(4):393-397. PubMed ID: 33078745
[TBL] [Abstract] [Full Text] [Related]
10. Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated thyroid cancer: Results of a Randomized, Multicenter Phase II Trial.
Lin YS; Yang H; Ding Y; Cheng YZ; Shi F; Tan J; Deng ZY; Chen ZD; Wang RF; Ji QH; Huang R; Li LF
Thyroid; 2021 Apr; 31(4):607-615. PubMed ID: 32907500
[No Abstract] [Full Text] [Related]
11. Pathogenic Germline Mutations in DNA Repair Genes in Combination With cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood cancer.
Qin N; Wang Z; Liu Q; Song N; Wilson CL; Ehrhardt MJ; Shelton K; Easton J; Mulder H; Kennetz D; Edmonson MN; Rusch MC; Downing JR; Hudson MM; Nichols KE; Zhang J; Robison LL; Yasui Y
J Clin Oncol; 2020 Aug; 38(24):2728-2740. PubMed ID: 32496904
[TBL] [Abstract] [Full Text] [Related]
12. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract] [Full Text] [Related]
13. [Mining and discovery for active components of "Coptidis Rhizome-Magnoliae Officinalis Cortex" based on network pharmacology].
Wu HN; Yu GH; Zhao FZ; Jia XB; Feng L; Shi XH
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):803-810. PubMed ID: 30989895
[TBL] [Abstract] [Full Text] [Related]
14. Imbalance in DNA repair machinery is associated with BRAF
Lutz BS; Leguisamo NM; Cabral NK; Gloria HC; Reiter KC; Agnes G; Zanella V; Meyer ELS; Saffi J
Mol Cell Endocrinol; 2018 Sep; 472():140-148. PubMed ID: 29229408
[TBL] [Abstract] [Full Text] [Related]
15. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
[TBL] [Abstract] [Full Text] [Related]
16. Polymorphism of DNA repair gene xpd Lys751Gln and chromosome aberrations in lymphocytes of thyroid cancer patients exposed to ionizing radiation due to the Chornobyl accident.
Shkarupa VM; Mishcheniuk OY; Henyk-Berezovska SO; Palamarchuk VO; Klymenko SV
Exp Oncol; 2016 Dec; 38(4):257-260. PubMed ID: 28230823
[TBL] [Abstract] [Full Text] [Related]
17. SHOULD MULTIFOCAL PAPILLARY thyroid CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
[TBL] [Abstract] [Full Text] [Related]
18. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract] [Full Text] [Related]
19. Confirmation of an anatomic variation of the recurrent laryngeal nerve at site of entry into the larynx in Chinese population.
Shao T; Qiu W; Yang W
Am J Otolaryngol; 2016; 37(4):351-5. PubMed ID: 26725328
[TBL] [Abstract] [Full Text] [Related]
20. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.
Pyo JS; Sohn JH; Kang G; Kim DH; Yun J
Yonsei Med J; 2015 Mar; 56(2):355-61. PubMed ID: 25683981
[TBL] [Abstract] [Full Text] [Related]
[Next]
